MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584811 | Name: NK 611 HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

NK 611 HCl is a new semisynthetic analogue of etoposide and has been found to be more potent against several cancer cell lines in vitro than etoposide.

Chemical Structure

NK 611 HCl
CAS#105760-98-3 (HCl)

Theoretical Analysis

MedKoo Cat#: 584811

Name: NK 611 HCl

CAS#: 105760-98-3 (HCl)

Chemical Formula: C31H38ClNO12

Exact Mass: 651.2083

Molecular Weight: 652.09

Elemental Analysis: C, 57.10; H, 5.87; Cl, 5.44; N, 2.15; O, 29.44

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
105655-99-0 (free acid); 105760-98-3 (HCl)
Synonym
NK 611; NK-611; NK611; NK 611 HCl
IUPAC/Chemical Name
Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((2-deoxy-2-(dimethylamino)-4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride, (5R-(5alpha,5abeta,8aalpha,9beta))-
InChi Key
PYLTTZZOZBYUEI-DZMPZKOJSA-N
InChi Code
InChI=1S/C31H37NO12.ClH/c1-13-38-11-22-29(42-13)27(34)25(32(2)3)31(43-22)44-28-16-9-19-18(40-12-41-19)8-15(16)23(24-17(28)10-39-30(24)35)14-6-20(36-4)26(33)21(7-14)37-5;/h6-9,13,17,22-25,27-29,31,33-34H,10-12H2,1-5H3;1H/t13?,17-,22+,23-,24-,25+,27+,28+,29+,31-;/m0./s1
SMILES Code
O=C1OC[C@]2([H])[C@H](O[C@H]3[C@H](N(C)C)[C@H]([C@@H]([C@@H](CO4)O3)OC4C)O)C5=C(C=C6OCOC6=C5)[C@H](C7=CC(OC)=C(O)C(OC)=C7)[C@]21[H].[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 652.09 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Hanauske AR, Wüster KC, Lehmer A, Rotter M, Schneider P, Kaeser-Fröhlich A, Rastetter J, Depenbrock H. Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro. Eur J Cancer. 1995 Sep;31A(10):1677-81. PubMed PMID: 7488424. 2: Hüttmann A, Mross K, Hossfeld DK. Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 1993 Oct 29;620(2):233-8. PubMed PMID: 8300791. 3: Mross K, Hüttmann A, Herbst K, Hanauske AR, Schilling T, Manegold C, Burk K, Hossfeld DK. Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOH. Cancer Chemother Pharmacol. 1996;38(3):217-24. PubMed PMID: 8646795. 4: Daley L, Guminski Y, Demerseman P, Kruczynski A, Etiévant C, Imbert T, Hill BT, Monneret C. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611. J Med Chem. 1998 Nov 5;41(23):4475-85. PubMed PMID: 9804687. 5: Takigawa N, Ohnoshi T, Ueoka H, Kiura K, Moritaka T, Tabata M, Segawa Y, Shibayama T, Gemba K, Matsumura T, et al. [In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines]. Gan To Kagaku Ryoho. 1993 Mar;20(4):473-7. Japanese. PubMed PMID: 8383949. 6: Capranico G, Giaccone G, Zunino F, Garattini S, D'Incalci M. DNA topoisomerase II poisons and inhibitors. Cancer Chemother Biol Response Modif. 1997;17:114-31. Review. PubMed PMID: 9551211. 7: Rassmann I, Thödtmann R, Mross M, Hüttmann A, Berdel WE, Manegold C, Fiebig HH, Kaeser-Fröhlich A, Burk K, Hanauske AR. Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion. Invest New Drugs. 1998-1999;16(4):319-24. PubMed PMID: 10426664. 8: Pagani O, Zucchetti M, Sessa C, de Jong J, D'Incalci M, De Fusco M, Kaeser-Fröhlich A, Hanauske A, Cavalli F. Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative. Cancer Chemother Pharmacol. 1996;38(6):541-7. PubMed PMID: 8823496. 9: De Fusco M, D'Incalci M, Gentili D, Reichert S, Zucchetti M. High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients. J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):409-14. PubMed PMID: 7780594. 10: Machida M, Tanaka S, Nakamori K. Simultaneous determination of NK611, a novel water-soluble derivative of etoposide, and its metabolite (DeNK611) in dog plasma by column-switching high performance liquid chromatography. Biomed Chromatogr. 1993 Mar-Apr;7(2):82-5. PubMed PMID: 8485379. 11: Rassmann I, Schrödel H, Schilling T, Zucchetti M, Kaeser-Fröhlich A, Rastetter J, Hanauske AR. Clinical and pharmacokinetic phase I trial of oral dimethylaminoetoposide (NK611) administered for 21 days every 35 days. Invest New Drugs. 1996;14(4):379-86. PubMed PMID: 9157073. 12: Zucchetti M, De Fusco M, Sessa C, Fröhlich A, Reichert S, D'Incalci M. High-performance liquid chromatographic assay for the determination of the novel podophyllotoxin derivative dimethylaminoetoposide (NK611) in human plasma. J Chromatogr B Biomed Appl. 1994 Mar 18;654(1):97-102. PubMed PMID: 8004249.

View History

Dimethindene maleate

Dimethindene maleate

Featured